In summary, we have generated stable monoclonal cell lines from a CLL mouse model that exhibits constitutive Btk and Akt signaling, presents several features of human CLL and responds to novel targeted therapies. Here, AKT1 is linked to B-cell chronic lymphocytic leukemia.